BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 22824371)

  • 1. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
    Harris PN; Ferguson JK
    Int J Antimicrob Agents; 2012 Oct; 40(4):297-305. PubMed ID: 22824371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
    Tan SH; Ng TM; Chew KL; Yong J; Wu JE; Yap MY; Heng ST; Ng WHW; Wan S; Cheok SJH; Tambyah PA; Lye DC
    Int J Antimicrob Agents; 2020 Feb; 55(2):105860. PubMed ID: 31841674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
    Tamma PD; Girdwood SC; Gopaul R; Tekle T; Roberts AA; Harris AD; Cosgrove SE; Carroll KC
    Clin Infect Dis; 2013 Sep; 57(6):781-8. PubMed ID: 23759352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review.
    Mizrahi A; Delerue T; Morel H; Le Monnier A; Carbonnelle E; Pilmis B; Zahar JR;
    Int J Antimicrob Agents; 2020 Feb; 55(2):105834. PubMed ID: 31682902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
    López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL
    Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020-2022.
    Boattini M; Bianco G; Llorente LI; Acero LA; Nunes D; Seruca M; Mendes VS; Almeida A; Bastos P; Rodríguez-Villodres Á; Gascón AG; Halperin AV; Cantón R; Escartín MNL; González-López JJ; Floch P; Massip C; Chainier D; Barraud O; Dortet L; Cuzon G; Zancanaro C; Mizrahi A; Schade R; Rasmussen AN; Schønning K; Hamprecht A; Schaffarczyk L; Glöckner S; Rödel J; Kristóf K; Balonyi Á; Mancini S; Quiblier C; Fasciana T; Giammanco A; Paglietti B; Rubino S; Budimir A; Bedenić B; Rubic Z; Marinović J; Gartzonika K; Christaki E; Mavromanolaki VE; Maraki S; Yalçın TY; Azap ÖK; Licker M; Musuroi C; Talapan D; Vrancianu CO; Comini S; Zalas-Więcek P; Michalska A; Cavallo R; Melo Cristino J; Costa C
    Int J Antimicrob Agents; 2024 May; 63(5):107115. PubMed ID: 38367844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
    Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
    J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence & detection of AmpC beta-lactamases at a referral hospital in Karnataka.
    Ratna AK; Menon I; Kapur I; Kulkarni R
    Indian J Med Res; 2003 Jul; 118():29-32. PubMed ID: 14748463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae.
    Akata K; Muratani T; Yatera K; Naito K; Noguchi S; Yamasaki K; Kawanami T; Kido T; Mukae H
    PLoS One; 2019; 14(7):e0218589. PubMed ID: 31283769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
    Mendes RE; Rhomberg PR; Bell JM; Turnidge JD; Sader HS
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use.
    Choi SH; Lee JE; Park SJ; Choi SH; Lee SO; Jeong JY; Kim MN; Woo JH; Kim YS
    Antimicrob Agents Chemother; 2008 Mar; 52(3):995-1000. PubMed ID: 18086837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
    J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.
    Kohlmann R; Bähr T; Gatermann SG
    J Antimicrob Chemother; 2018 Jun; 73(6):1530-1536. PubMed ID: 29566147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.